International Journal of Drug Policy
Volume 20, Issue 1 , Pages 14-27, January 2009

Ethical and regulatory considerations in HIV prevention studies employing respondent-driven sampling☆☆☆

  • Salaam Semaan

      Affiliations

    • Centers for Disease Control and Prevention, 1600 Clifton Road, NE, E-07, Atlanta, GA 30333, United States
    • Corresponding Author InformationCorresponding author. Tel.: +1 404 639 8870; fax: +1 404 639 8600.
    • ,
  • Scott Santibanez

      Affiliations

    • Centers for Disease Control and Prevention, 1600 Clifton Road, NE, E-73, Atlanta, GA 30333, United States
    • ,
  • Richard S. Garfein

      Affiliations

    • School of Medicine, University of California San Diego, San Diego, CA, United States
    • ,
  • Douglas D. Heckathorn

      Affiliations

    • Department of Sociology, Cornell University, Ithaca, NY, United States
    • ,
  • Don C. Des Jarlais

      Affiliations

    • Beth Israel Medical Center, New York, NY, United States

Received 29 June 2007; received in revised form 28 November 2007; accepted 5 December 2007. published online 13 February 2008.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

☆ An earlier version of this paper was presented at the XV International AIDS conference, Bangkok, Thailand, 15 July 2004 and at the U.S. National HIV Prevention Conference, Atlanta, GA, 4 December 2007.

☆☆ The findings and conclusions in this paper are those of the authors and do not necessarily represent the views of the Centers for Disease Control and Prevention.

PII: S0955-3959(07)00265-4

doi:10.1016/j.drugpo.2007.12.006

International Journal of Drug Policy
Volume 20, Issue 1 , Pages 14-27, January 2009

Article Tools